Project Grant R01MD021739
Award Date 7/19/26
Completion Date 1/31/31
Dollars Obligated $1.3M
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
- The National Cancer Institute awarded Icahn School of Medicine at Mount Sinai $711,272 on July 1, 2026, for research to identify optimal lung cancer screening strategies in people living with HIV under the Cancer Treatment Research program (CFDA 93.395). The research addresses lung cancer mortality among people with HIV, which now represents the leading source of cancer deaths in this population. Most lung cancers in people with HIV are diagnosed at late stages with poor survival outcomes. The...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded Icahn School of Medicine at Mount Sinai $165,509 on August 5, 2026, under the Trans-NIH Research Support program (CFDA 93.310) to conduct a mixed-methods study examining exposure to incarceration among community-dwelling older adults and its effects on health, mechanisms of harm, and sources of resilience. The research addresses three specific aims: describing health effects of exposure to...
- The National Heart, Lung, and Blood Institute awarded Icahn School of Medicine at Mount Sinai $850,669 on August 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate place-based drivers of health in sickle cell disease pathogenesis. The project will identify and quantify mechanisms linking neighborhood and personal exposures—including crime-related stressors, unhealthy food access, temperature, airborne particulates, and housing conditions—to clinical...
- The National Heart, Lung, and Blood Institute of the Department of Health and Human Services awarded Icahn School of Medicine at Mount Sinai $809,307 on July 1, 2026, for a Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837, R01HL183991). The award funds population-based genomic screening for transthyretin amyloidosis (ATTRV), a treatable cardiovascular and neuropathic condition caused by mutations in the TTR gene that disproportionately affects African American and...
- The National Institute for Minority Health and Health Disparities awarded George Washington University $2,745,450 on September 19, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307) to evaluate an SMS text-based patient navigation intervention for colorectal cancer screening among persons experiencing homelessness. The project will deploy mHealth-based navigation through shelter-clinics operated by Project Renewal, a community organization serving the...
- The National Institute for Minority Health and Health Disparities awarded Oregon Health & Science University $3,117,935 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop and test a culturally tailored home-based cervical and colorectal cancer screening intervention for American Indian and Alaska Native tribal communities. The funded work, titled "American Indian/Alaska Native Tailoring of a Home-Based Cervical and Colorectal...
- Federal Project Grant Award Summary Icahn School of Medicine at Mount Sinai (ISMMS) received a $466,809 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025, through August 31, 2028. The award supports research titled "Identification of Recessive Prostate Cancer Risk Alleles in the Million Veterans Program," which will be conducted at ISMMS's facility in New York, NY. This...
- The National Cancer Institute awarded Albert Einstein College of Medicine $199,584 on May 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to examine the association between neighborhood disadvantage and obesity-related cancer incidence in US Hispanic and Latino populations. The research leverages the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), the largest prospective multicenter cohort study of US Hispanic and Latino populations. The project will assess how...
- The National Heart, Lung, and Blood Institute awarded Icahn School of Medicine at Mount Sinai $672,958 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct research on task-shifting models for hypertension care in low-resource rural settings. The research project, titled "Task-Shifting at the Doorstep of the People: Strengthening the Hypertension Care Continuum Within Primary Health Care in a Low-Resource Setting," develops and tests...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded Icahn School of Medicine at Mount Sinai a $2.69 million Project Grant under the Cancer Biology Research program (CFDA 93.396) on September 24, 2025, with completion scheduled for August 31, 2029. This award supports fundamental research investigating the mechanisms and impact of Neuregulin 3 (NRG3) induction in bone metastasis of breast cancer. The project will employ molecular and genetic approaches to...